Skip to content

Investor Relations / Press Releases

Press Releases

The press releases contained in this section of the website are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Amarin disavows any obligation to update the information contained in such press releases after the date of their issuance.

Date Title and Summary Additional Formats
Toggle Summary Amarin Reports Third Quarter 2010 Financial Results and Positively Updates Phase 3 Guidance
-Phase 3 milestones moved ahead into 2010 for report of top line results of MARINE trial and completion of ANCHOR trial randomization-Conference call today at 11:00 AM Eastern Time
View HTML
Toggle Summary Amarin Corporation Announces Senior Management Changes
-Conference call today at 11:00 AM Eastern Time-
View HTML
Toggle Summary Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
DUBLIN and MYSTIC, Conn. , Nov. 9, 2010 /PRNewswire-FirstCall/ -- Amarin Corporation plc (Nasdaq: AMRN) has scheduled a conference call for Wednesday, November 10, 2010 at 11:00 am Eastern Time ( 4:00 pm UTC /GMT) to discuss selected financial and operating results from the third quarter, including
View HTML
Toggle Summary Amarin to Present at Oppenheimer & Co. Inc. Annual Healthcare Conference
DUBLIN and MYSTIC, Conn., Oct 28, 2010 /PRNewswire via COMTEX News Network/ -- Amarin Corporation plc (Nasdaq: AMRN) today announced that Dr. Declan Doogan, Chief Medical Officer, is scheduled to present on Amarin's behalf at the Oppenheimer & Co. Inc.
View HTML
Toggle Summary Amarin to Present at NewsMakers in the Biotech Industry Conference
DUBLIN and MYSTIC, Conn., Oct 18, 2010 /PRNewswire via COMTEX News Network/ -- Amarin Corporation plc (Nasdaq: AMRN) today announced that Dr. Declan Doogan, Chief Medical Officer, is scheduled to present on Amarin's behalf at the NewsMakers in the Biotech Industry Conference on Friday, October 22,
View HTML
Toggle Summary Amarin to Present at UBS Life Sciences Conference
DUBLIN and MYSTIC, Conn., Sept 16, 2010 /PRNewswire via COMTEX News Network/ -- Amarin Corporation plc (Nasdaq: AMRN) today announced that John Thero, Chief Financial Officer, is scheduled to present on Amarin's behalf at the Global UBS Life Sciences Conference on Wednesday, September 22, 2010 at
View HTML
Toggle Summary AMARIN CORPORATION APPOINTS COLIN W. STEWART AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
AMARIN CORPORATION APPOINTS COLIN W. STEWART AS PRESIDENT AND CHIEF EXECUTIVE OFFICER Dublin, Ireland and Mystic, Connecticut, USA, August 17, 2010 – Amarin Corporation plc (NASDAQ: AMRN), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that Colin
View HTML
Toggle Summary AMARIN REPORTS Q2 2010 RESULTS
-MARINE trial results due early 2011; ANCHOR trial >50% randomized-Conference call today
View HTML
Toggle Summary AMARIN’S AMR101 PIVOTAL PHASE 3 MARINE CLINICAL TRIAL COMPLETES PATIENT ENROLLMENT AND RANDOMIZATION
- Trial Guidance Positively Updated -
View HTML
Toggle Summary AMARIN CORPORATION to HOST INVESTOR CONFERENCE CALL ON TUESDAY, AUGUST 10, 2010
AMARIN CORPORATION to HOST INVESTOR CONFERENCE CALL ON TUESDAY, AUGUST 10, 2010 Dublin, Ireland and Mystic, CT, USA, August 3, 2010 – Amarin Corporation plc (NASDAQ: AMRN) has scheduled a conference call for Tuesday, August 10, 2010 at 4:00 pm UTC/GMT + 1 hour (11:00 am Eastern Time) to discuss
View HTML

Amarin Corporation